Analyst Ratings for Cyclacel Pharmaceuticals (CYCC) [Neutrals]
Avg. $ Target:
N/A
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/19/2023 | Brookline Capital Markets | Kumaraguru Raja | Downgrade | Hold (Buy) |
N/A (N/A) |
3.69 (2.11) |
-42.82% | Details |
| 12/17/2014 | JMP Securities | N/A | Downgrade | Market Perform (Market Outperform) |
N/A (9.00) |
0.68 (2.11) |
210.29% | Details |
